Abstract:Background: Osteoarthritis (OA) is a complex and heterogeneous condition, and one of the most common degenerative joint diseases. A standardized OA classification based on molecular criteria has yet to be defined. We performed transcriptomic profiling to determine the different molecular signatures associated with knee OA phenotypes. Methods: Five centres clinical research with next-generation sequencing was carried out using 201 samples from patients with knee osteoarthritis. Transcriptomic analysis and unsupervised clustering methods were performed on 131 cartilage samples. To investigate tissue crosstalk of the whole knee microenvironment, transcriptomic analysis was performed in 60 synovia and 65 subchondral bone samples. Findings: We identified four OA subgroups with distinct biological signatures: 1) the glycosaminoglycan metabolic disorder subgroup highly expressed ACAN, lowly expressed VCAN, and was enriched with glycosaminoglycan metabolic functions; 2) the collagen metabolic disorder subgroup presented with osteophyte formation, highly expressed COL1A1 and COL6A1, and was enriched with collagen catabolic functions; 3) the sensory neurons activated subgroup highly expressed GRIK2 and GRM7, and was enriched with synapse assembly functions; and 4) the immunogenic subgroup presented with high inflammation and narrow joint space, highly expressed IL1ÃŸ and CD34, and was enriched with immune responses. We also explored immune cell composition and tissue crosstalk for three identified metabolic disorder subgroups. Interpretation: These findings challenge the classical diagnosis model based on medical imaging, revealing distinct molecular subgroups in knee OA patients, and opening the door to precision diagnosis and treatment of OA. Funding Statement: This work was financially supported by the National Key R&D Program of China (2017YFA0104902), the National Natural Science Foundation of China (81630065, 31830029, 81802195) grants and China Postdoctoral Science Foundation (2017M621913). Declaration of Interests: The authors declare no competing interests.Ethics Approval Statement: Informed consent was obtained from all the participants. The study was approved by the local clinical ethics committees of Zhejiang University School of Medicine and the affiliated hospital of Wenzhou Medical University (2017KYLL11).

An insight into osteoarthritis susceptibility: Integration of immunological and genetic background

Osteoarthritis: Novel Molecular Mechanisms Increase Our Understanding of the Disease Pathology

Interplay between genetics and epigenetics in osteoarthritis

Identification of osteoarthritis-characteristic genes and immunological micro-environment features through bioinformatics and machine learning-based approaches

Osteoarthritis: Insights into Diagnosis, Pathophysiology, Therapeutic Avenues, and the Potential of Natural Extracts

Key Players in Osteoarthritis Progression

Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis

The Role of Innate Immunity in Osteoarthritis: When Our First Line of Defense Goes On the Offensive

The Role of Genetics and Epigenetic Regulation in the Pathogenesis of Osteoarthritis

Bioinformatic analysis combined with immune infiltration to explore osteoarthritis biomarkers and drug prediction

Osteoarthritis: toward a comprehensive understanding of pathological mechanism

Insights into osteoarthritis progression revealed by analyses of both knee tibiofemoral compartments

Age-dependent genetic regulation of osteoarthritis: independent effects of immune system genes

Role of Inflammation and the Immune System in the Progression of Osteoarthritis

Identification of novel drug targets for osteoarthritis by integrating genetics and proteomes from blood

Recognition of Immune Response for the Early Diagnosis and Treatment of Osteoarthritis

Knee Osteoarthritis Molecular Subgroups Revealed by Pathogenic Joint Gene Expression

The role of immune factors in the etiopathogenesis of osteoarthritis

Genetics of osteoarthritis

Identification of therapeutic targets in osteoarthritis by combining heterogeneous transcriptional datasets, drug-induced expression profiles, and known drug-target interactions

The Role of Innate Immunity in Osteoarthritis and the Connotation of "Immune-joint" Axis: A Narrative Review